Simmons Jeffrey N's Form 4 filing
Elanco Animal Health Inc (ELAN) · filed Dec 15, 2025
- Accession no.
- 0001479079-25-000017
- Filed
- Dec 15, 2025
- Trade date
- Dec 11, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $478.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simmons Jeffrey NCIK 0001479079 | Director, Officer (PRESIDENT, CEO AND DIRECTOR) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Common Stock | PPurchaseAcquired | +22,000 | $21.75F1 | +$478,500 | 167,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects the weighted average price of 22,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on December 11, 2025 with purchase prices ranging from $21.739 to $21.75 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.